The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health

by Robert F. Kennedy Jr.

Following drug approval, Dr. Fauci continues to collaborate with his pharmaceutical partners on promoting and pricing and profiting from their new product. Over the decades since Dr. Fauci took over NIAID, the agency has formalized an elaborate process of negotiating against US taxpayers to allow Pharma to extract maximum profits back from NIAID’s germinated drugs. With NIAID’s help, the lucky pharmaceutical company walks the new drug through accelerated FDA approval. The CDC then sets obscene retail prices for these collaborative products in secretive negotiations. Such sweetheart deals—at taxpayer and consumer expense—and accelerated approvals can yield direct financial benefits to NIAID, to Dr. Fauci’s favored employees, and even to Dr. Fauci himself.